GILD
GILEAD SCIENCES, INC.
GILEAD SCIENCES, INC. (GILD) has 9 SEC Form 4 filings (29 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 16, 2026.
The most active filer is Chief Financial Officer Dickinson Andrew D with 3 filings. Insiders have net sold $8.4M over the trailing 6 months.
- Industry:Drug Manufacturers - General
- CEO:Daniel O'Day
- Employees:17,600
- HQ:Foster City, CA, US
- IPO:1992-01-22
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$18.2M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$169.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Financial Officer | Sale | 3,000 | $390K | Jul 16 | SEC ↗ | |
| Chief Comm & Corp Aff Officer | Sale | 3,000 | $390K | Jul 16 | SEC ↗ | |
| Chairman & CEO | Sale | 15,000 | $1.9M | Jul 2 | SEC ↗ | |
| Chief Financial Officer | Sale | 3,000 | $376K | Jun 16 | SEC ↗ | |
Dickinson Andrew DFirst filing | Chief Financial Officer | Sale | 3,000 | $397K | May 18 | SEC ↗ |
Mercier JohannaFirst in 9 months | Chief Comm & Corp Aff Officer | Sale | 28,000 | $3.7M | May 18 | SEC ↗ |
O'Day Daniel PatrickFirst filing | Chairman & CEO | Sale | 10,000 | $1.3M | Apr 29 | SEC ↗ |
Telman Deborah HFirst filing | EVP, Corporate Affairs & GC | Sale | 53,646 | $6.6M | Nov 13 | SEC ↗ |
Mercier JohannaFirst filing | Chief Commercial Officer | Sale | 27,300 | $3.2M | Aug 18 | SEC ↗ |
Congress trading GILD
See timeline →- DRep. Jared MoskowitzPurchase$1,001 - $15,0002026-05-06
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
GILEAD SCIENCES, INC. is in the Healthcare sector.